IDiyas

For the Inventor, By the Inventor

Needham, MA, United States of America

Stealth Biotherapeutics Inc.


USPTO Granted Patents = 69



Trademarks = 15

Forward Citations = 178

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal D Travis Wilson (41 out of 42 patents)

silverMedal Scott M Duncan (16 out of 37 patents)

bronzeMedal Mark J Bamberger (10 out of 11 patents)

4.  Guozhu Zheng (8 out of 8 patents)

5.  Robert A Kloner (6 out of 7 patents)

6.  Martin P Redmon (6 out of 14 patents)

7.  Dennis Keefe (5 out of 5 patents)

8.  Liping Liu (4 out of 34 patents)

9.  Shibo Tang (4 out of 6 patents)

10.  Xiaoling Liang (4 out of 6 patents)

11.  Marc W Andersen (3 out of 14 patents)

12.  Inese Smukste (3 out of 3 patents)

13.  Vania Broccoli (2 out of 2 patents)

14.  Kenneth Borow (2 out of 2 patents)

15.  Sharon Hale (2 out of 2 patents)


Core Competencies:
Mitochondria-Targeting Peptides
Mitochondrial Diseases
Friedreich's Ataxia
Barth Syndrome
Aromatic-Cationic Peptides
Amyotrophic Lateral Sclerosis
Pharmaceutical Compositions
Crystalline Salt Forms
Neuropathy Treatment
Matrix Metalloproteinase Regulation
Chemotherapeutic Agents

69 patents:

1. 12404300 - Mitochondria-targeting peptides (2025-09-02),
2. 12337023 - Methods and compositions for the prevention and treatment of disease (2025-06-24),
3. 12297502 - Methods and compositions for detecting and diagnosing diseases and conditions (2025-05-13),
4. 12268724 - Methods and compositions for the prevention or treatment of Barth Syndrome (2025-04-08),
5. 12252554 - Analogs that target mitochondrial diseases (2025-03-18),
6. 12252553 - Crystalline salt forms (2025-03-18),
7. 12110345 - Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH (2024-10-08),
8. 12065511 - Aromatic-cationic peptides and uses of same (2024-08-20),
9. 12049455 - Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia (2024-07-30),
10. 12037414 - Processes for preparing pharmaceutically relevant peptides (2024-07-16),
11. 12037350 - Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia (2024-07-16),
12. 12018094 - Crystalline dipeptides useful in the synthesis of elamipretide (2024-06-25),
13. 12016843 - Compositions and methods for the treatment of amyotrophic lateral sclerosis, parkinson's disease, parkinson's disease with dementia, dementia with lewy bodies, and multiple system atrophy (2024-06-25),
14. 11998585 - Methods and compositions for increasing the dose of a chemotherapeutic agent (2024-06-04),
15. 11944662 - Methods and compositions for preventing or treating ophthalmic conditions (2024-04-02),
Stealth BioTherapeutics Inc. is a biotechnology company focused on developing innovative therapies for diseases involving mitochondrial dysfunction. With a dedication to precision medicine, Stealth BioTherapeutics utilizes their proprietary mitochondrial-targeted platform to develop treatments for rare genetic disorders, ophthalmic diseases, and diverse therapeutic areas. Through their robust research and development efforts, Stealth BioTherapeutics aims to revolutionize patient care and improve lives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

69 Patents

#2 in Needham, MA

#286 in Massachusetts

#5,083 in US

#10,329 in the World

...
Needham, MA, United States of America

Stealth Biotherapeutics Inc.

Forward Citations = 178

30 inventors:

goldMedal D Travis Wilson (41 out of 42 patents)

silverMedal Scott M Duncan (16 out of 37 patents)

bronzeMedal Mark J Bamberger (10 out of 11 patents)

4.  Guozhu Zheng (8 out of 8 patents)

5.  Robert A Kloner (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…